The history and rationale of using carbonic anhydrase inhibitors in the treatment of peptic ulcers. In memoriam Ioan Puşcaş (1932–2015)
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The history and rationale of using carbonic anhydrase inhibitors in the treatment of peptic ulcers. In memoriam Ioan Puşcaş (1932–2015)
Authors
Keywords
-
Journal
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
Volume 31, Issue 4, Pages 527-533
Publisher
Informa UK Limited
Online
2015-06-25
DOI
10.3109/14756366.2015.1051042
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Building a Comprehensive Mill-Level Database for the Industrial Sectors Integrated Solutions (ISIS) Model of the U.S. Pulp and Paper Sector
- (2015) Nabanita Modak et al. PLoS One
- An overview of the alpha-, beta- and gamma-carbonic anhydrases fromBacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria?
- (2014) Clemente Capasso et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- 3D-QSAR CoMFA studies on sulfonamide inhibitors of the Rv3588c β-carbonic anhydrase fromMycobacterium tuberculosisand design of not yet synthesized new molecules
- (2013) Shalini Singh et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnological use for CO2 capture
- (2013) Claudiu T. Supuran JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Sulfa and trimethoprim-like drugs – antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors
- (2013) Clemente Capasso et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Carbonic anhydrase inhibitors. Phenols incorporating 2- or 3-pyridyl-ethenylcarbonyl and tertiary amine moieties strongly inhibitSaccharomyces cerevisiaeβ-carbonic anhydrase
- (2013) Sinan Bilginer et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
- (2012) Vincenzo Alterio et al. CHEMICAL REVIEWS
- Sulfonamides: a patent review (2008 – 2012)
- (2012) Fabrizio Carta et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Three new aromatic sulfonamide inhibitors of carbonic anhydrases I, II, IV and XII
- (2012) C. T. Supuran et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Structure-based drug discovery of carbonic anhydrase inhibitors
- (2012) Claudiu T. Supuran JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Inhibition of the alpha- and beta-carbonic anhydrases from the gastric pathogenHelycobacter pyloriwith anions
- (2012) Alfonso Maresca et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Carbonic anhydrase I and II activation with mono- and dihalogenated histamine derivatives
- (2011) Mohamed-Chiheb Saada et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Interfering with pH regulation in tumours as a therapeutic strategy
- (2011) Dario Neri et al. NATURE REVIEWS DRUG DISCOVERY
- Bacterial Carbonic Anhydrases as Drug Targets: Toward Novel Antibiotics?
- (2011) Claudiu T. Supuran Frontiers in Pharmacology
- Carbonic anhydrase inhibitors
- (2010) Claudiu T. Supuran BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The α and β Classes Carbonic Anhydrases from Helicobacter pylori as Novel Drug Targets
- (2008) Hiroaki Takeuchi et al. CURRENT PHARMACEUTICAL DESIGN
- Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
- (2008) Claudiu T. Supuran NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started